Nightingale, Dr Julia

BA, BM BCh, MRCP. PhD

Speciality

Respiratory Medicine

Sub-speciality

Cystic Fibrosis

Training and Education

BA  Oxford University, 1988
BM BCh  Oxford University, 1991
MRCP  Royal College of Physicians, UK 1994
PhD  Imperial College, London  1999

Experience

Dr Nightingale has worked for Southampton University Hospitals Trust since August 2005. 

I am a respiratory physician with a major subspecialist role to provide regional services for adult cystic fibrosis (CF) patients. Additionally, I have a weekly general respiratory clinic which includes many patients with lung cancer, regular bronchoscopy lists and I support the consultant respiratory and Medical High Dependency Unit rota.

My main motivation throughout my work is the delivery of high quality, patient–centred care. This is especially important in patients with CF; a group of adolescent and young adult patients with chronic disease requiring frequent contact with health services. As such I have led on a number of initiatives including streamlining our process of annual review to shorten it for patients (as well as making it more efficient for the team), improving patient information for existing patients and to introduce the service to new patients. I am presently in the process of setting up an evening clinic to improve access to care for patients with work commitments. I am actively involved in improving patient care through the education of other healthcare professionals involved in the care of CF patients, including writing a set of clinical guidelines for doctors providing CF care whilst on call and education of all members of the multi-disciplinary team both within the hospital and the region.

Key achievements

I have written a successful grant applicatoin for funding from the CF Trust for a one year training programme to train an adult CF physician. 

Research

My previous research interests and have been in airways inflammation, asthma and respiratory side-effects of topical beta-antagonists. My PhD was on airways inflammation in humans. I have written seven first author papers and am co-author of a further six published in peer-reviewed journals. I have also co-written chapters in two respiratory textbooks.

Publications since 2000:
No effect of Inhaled Budesonide on the Response to Inhaled Ozone in Normal Subjects.
Nightingale et al. Am J Respir Crit Care Med 2000; 161:479-486.

Airway inflammation after controlled exposure to diesel exhaust particulates.
Nightingale et al. Am J Respir Crit Care Med 2000; 162:161-166.

Comparison of the effects of salmeterol and formoterol in patients with severe asthma.
Nightingale et al. Chest 2002; 121:1401-1406.

Blockers for glaucoma and excess risk of airways obstruction: population based cohort study. Kirwan, Nightingale, Bunce & Wormald. BMJ 2002; 325:1396-1397.

Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide. Montuschi, Nightingale, Kharitonov & Barnes. Free Radical Biology and Medicine 2002; 33:1403-1408.

Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols.
Usmani, Biddiscombe, Nightingale, Underwood & Barnes. J Appl Physiol 2003; 95:2106-2112.

Do selective topical  antagonists for glaucoma have respiratory side effects?
Kirwan, Nightingale, Bunce & Wormald. British Journal of Ophthalmology  2004; 88:196-8.

Gene therapy (GT); what adults with CF really think. A multi-centred study. Richards, Duff, Morton, Gumery, Ketchell, Nightingale & Conway. J Cystic Fibrosis 2008, 7 (suppl 2):S110.

An easily overlooked cause of chronic lung disease.
Arulrajan, Harden &  Nightingale. Student BMJ 2008; 16:330.